Yves Leblanc

2.8k total citations
64 papers, 1.8k citations indexed

About

Yves Leblanc is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Yves Leblanc has authored 64 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 20 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Yves Leblanc's work include Carbohydrate Chemistry and Synthesis (11 papers), Inflammatory mediators and NSAID effects (7 papers) and Receptor Mechanisms and Signaling (5 papers). Yves Leblanc is often cited by papers focused on Carbohydrate Chemistry and Synthesis (11 papers), Inflammatory mediators and NSAID effects (7 papers) and Receptor Mechanisms and Signaling (5 papers). Yves Leblanc collaborates with scholars based in Canada, United States and United Kingdom. Yves Leblanc's co-authors include Brian J. Fitzsimmons, Joshua Rokach, Helen J. Mitchell, Claude Dufresne, Michael A. Bernstein, Pascale Lehoux, Claude Sicotte, Denis Riendeau, Jillian F. Evans and Zhaoyin Wang and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Analytical Chemistry.

In The Last Decade

Yves Leblanc

64 papers receiving 1.7k citations

Peers

Yves Leblanc
Roger C. Whitehead United Kingdom
David S. Garvey United States
Nobuo Ikota Japan
Gerd Dannhardt Germany
Mark A. Rizzacasa Australia
Jacques H. Poupaert Belgium
Andrea Carotti Italy
Síbel Süzen Türkiye
Alan P. Watt United States
Kiyoshi Fukuhara Japan
Roger C. Whitehead United Kingdom
Yves Leblanc
Citations per year, relative to Yves Leblanc Yves Leblanc (= 1×) peers Roger C. Whitehead

Countries citing papers authored by Yves Leblanc

Since Specialization
Citations

This map shows the geographic impact of Yves Leblanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Leblanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Leblanc more than expected).

Fields of papers citing papers by Yves Leblanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Leblanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Leblanc. The network helps show where Yves Leblanc may publish in the future.

Co-authorship network of co-authors of Yves Leblanc

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Leblanc. A scholar is included among the top collaborators of Yves Leblanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Leblanc. Yves Leblanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaswani, Rishi G., Brian K. Albrecht, James E. Audia, et al.. (2014). A Practical Synthesis of Indoles via a Pd-Catalyzed C–N Ring Formation. Organic Letters. 16(16). 4114–4117. 28 indexed citations
2.
Powell, David, W. Cameron Black, Kelly Bleasby, et al.. (2011). Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy. Bioorganic & Medicinal Chemistry Letters. 21(24). 7281–7286. 15 indexed citations
3.
Boyd, Michael J., John Colucci, Carl Berthelette, et al.. (2011). New indole amide derivatives as potent CRTH2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(11). 3471–3474. 15 indexed citations
4.
Leblanc, Yves, Carl Berthelette, Carmela Molinaro, et al.. (2010). Azaindoles as potent CRTH2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 841–845. 21 indexed citations
5.
Leblanc, Yves, Patrick Roy, Claude Dufresne, et al.. (2009). Discovery of potent and selective DP1 receptor antagonists in the azaindole series. Bioorganic & Medicinal Chemistry Letters. 19(8). 2125–2128. 9 indexed citations
6.
Léger, Serge, W. Cameron Black, Denis Deschênes, et al.. (2009). Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438). Bioorganic & Medicinal Chemistry Letters. 20(2). 499–502. 55 indexed citations
7.
Han, Yongxin, Michel Belley, Christopher I. Bayly, et al.. (2008). Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(11). 3200–3205. 50 indexed citations
8.
Beaulieu, Christian, Daniel Guay, Zhaoyin Wang, et al.. (2008). Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold. Bioorganic & Medicinal Chemistry Letters. 18(8). 2696–2700. 35 indexed citations
9.
Asante‐Appiah, Ernest, Sangita B. Patel, Caroline Desponts, et al.. (2006). Conformation-assisted Inhibition of Protein-tyrosine Phosphatase-1B Elicits Inhibitor Selectivity over T-cell Protein-tyrosine Phosphatase. Journal of Biological Chemistry. 281(12). 8010–8015. 36 indexed citations
10.
Leblanc, Yves, Patrick Roy, Zhaoyin Wang, et al.. (2002). Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile. Bioorganic & Medicinal Chemistry Letters. 12(22). 3317–3320. 13 indexed citations
11.
Thérien, Michel, Jacques Yves Gauthier, Yves Leblanc, et al.. (2001). Synthesis of Rofecoxib, (MK 0966, Vioxx® 4-(4′-Methylsulfonylphenyl)-3-Phenyl-2(5H)-Furanone), a Selective and Orally Active Inhibitor of Cyclooxygenase-2. Synthesis. 2001(12). 1778–1779. 31 indexed citations
12.
Monetta, Laura, et al.. (2000). Comparación de Déficits Semánticos Asociados a una Lesión Cerebral Derecha o Izquierda Mediante una Prueba de Evocación Lexical Libre. 2(4). 3–20. 2 indexed citations
13.
Leblanc, Yves, Claude Dufresne, Rajiv Dhawan, et al.. (2000). Dimerization of conjugated 1-indanones. Canadian Journal of Chemistry. 78(6). 784–790. 3 indexed citations
14.
Naccache, Paul H., Yves Leblanc, Joshua Rokach, et al.. (1991). Calcium mobilization and right-angle light scatter responses to 12-oxo-derivatives of arachidonic acid in neutrophils: evidence for the involvement of the leukotriene B4 receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1133(1). 102–106. 12 indexed citations
15.
Leblanc, Yves, Robert Zamboni, & Michael A. Bernstein. (1991). Amination of olefinic compounds with bis(2,2,2-trichloroethyl) azodicarboxylate. The Journal of Organic Chemistry. 56(5). 1971–1972. 39 indexed citations
16.
Leblanc, Yves, et al.. (1991). Synthesis of 2-amino C-glucosides and 2-amino C-glucosides spiroketals. Tetrahedron Letters. 32(38). 5021–5024. 24 indexed citations
17.
Falgueyret, Jean‐Pierre, Yves Leblanc, & Denis Riendeau. (1990). Stereoselective carbonyl reductases from rat skin and leukocyte microsomes converting 12‐ketoeicosatetraenoic acid to 12(S)‐HETE. FEBS Letters. 262(2). 197–200. 12 indexed citations
18.
Pleasance, Stephen, et al.. (1990). Analysis of domoic acid and related compounds by mass spectrometry and gas chromatography/mass spectrometry asN-trifluoroacetyl-O-silyl derivatives. Journal of Mass Spectrometry. 19(7). 420–427. 20 indexed citations
19.
Falgueyret, Jean‐Pierre, Yves Leblanc, Joshua Rokach, & Denis Riendeau. (1988). NAD(P)H-dependent reduction of 12-ketoeicosatetraenoic acid to 12(R)-and 12(S)-hydroxyeicosatetraenoic acid by rat liver microsomes. Biochemical and Biophysical Research Communications. 156(3). 1083–1089. 18 indexed citations
20.
Charleson, S., Jillian F. Evans, Robert Zamboni, et al.. (1986). Leukotriene B3, leukotriene B4 and leukotriene B5; Binding to leukotriene B4 receptors on rat and human leukocyte membranes. Prostaglandins. 32(4). 503–516. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger C. Whitehead Breakdown of academic impact, for papers by David S. Garvey Breakdown of academic impact, for papers by Nobuo Ikota Breakdown of academic impact, for papers by Gerd Dannhardt Breakdown of academic impact, for papers by Mark A. Rizzacasa Breakdown of academic impact, for papers by Jacques H. Poupaert Breakdown of academic impact, for papers by Andrea Carotti Breakdown of academic impact, for papers by Síbel Süzen Breakdown of academic impact, for papers by Alan P. Watt Breakdown of academic impact, for papers by Kiyoshi Fukuhara
Rankless by CCL
2026